Oswald, Ailsa J. http://orcid.org/0000-0002-0702-3892
Symeonides, Stefan N.
Wheatley, Duncan
Chan, Stephen
Brunt, Adrian Murray
McAdam, Karen
Schmid, Peter
Waters, Simon
Poole, Christopher
Twelves, Chris
Perren, Timothy
Bartlett, John
Piper, Tammy
Chisholm, Eve Macdonald
Welsh, Michelle
Hill, Robert
Hopcroft, Lisa E. M.
Barrett-Lee, Peter
Cameron, David A.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study
https://doi.org/10.1007/s10549-023-06873-8
Funding for this research was provided by:
AstraZeneca
Article History
Received: 21 December 2022
Accepted: 31 January 2023
First Online: 2 March 2023
Declarations
:
: Dr Oswald holds a clinical research fellowship at the University of Edinburgh that is supported by funding from AstraZeneca. At the time of the trial, Dr Symeonides held a clinical fellowship with the University of Edinburgh and AstraZeneca. The remaining authors declare no competing interests. AO: AstraZeneca funded clinical research fellowship (University of Edinburgh) from August 2020 to present. SS: AstraZeneca clinical fellowship (University of Edinburgh) from November 2012 to September 2014. DW, SC, AMB, KM, PS, SW, CP, CT, TPe, JB, TPi, EMC, MW, RH, LH and P B-L: No competing interests to disclose. DC: At the time the trial was conducted DC had no competing interests, but now has non-personal potential conflicts with Pfizer, Astra-Zenca, Novartis and Lilly.This trial was presented as a poster at the San Antonio Breast Cancer Symposium in 2019 [CitationRef removed].
: Ethics Committee approval was obtained from the West of Scotland Research Ethics Service and the trial was registered with appropriate databases (EudraCT 2011–002157-64, ISRCTN23804370, CRUKE/11/023). The study was conducted in accordance with the ethical principles that have their origins in the Declaration of Helsinki.
: All patient provided written informed consent before participating in the study.
: All patient provided written informed consent before participating in the study.